Results 91 to 100 of about 33,479 (238)

Chemoembolization agents for cancer treatment

European Journal of Pharmaceutical Sciences, 2011
Chemoembolization has been used in the field of interventional oncology. Although practiced widely, it has only recently been demonstrated that the use of transarterial chemoembolization (TACE) provides a survival benefit based on randomized controlled trials.
Kin Y, Tam, Ken Cham-Fai, Leung, Yi-Xiang J, Wang   +2 more
openaire   +2 more sources

Rapid Intrasegmental Progression After Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma: Incidence, Imaging Features, and Clinical Outcomes

Hepatology Research, EarlyView.
ABSTRACT Aim Radiofrequency ablation (RFA) is curative therapy for early‐stage hepatocellular carcinoma (HCC), but a rare subset of patients develop aggressive intrasegmental recurrence shortly after complete ablation. We characterized the incidence, risk factors, and absolute risk.
Takuma Kaneko, Takuma Nakatsuka, Ryosuke Tateishi, Keisuke Mabuchi, Yuki Matsushita, Tomoharu Yamada, Tatsuya Minami, Masaya Sato, Mitsuhiro Fujishiro   +8 more
wiley   +1 more source

Safety and efficacy of transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the treatment of secondary liver malignancies [PDF]

, 2018
Purpose: To evaluate the safety and efficacy of degradable starch microspheres (DSM) as embolic agents in transarterial chemoembolization (TACE) in the treatment of secondary liver metastases. Methods: This was a national, multicenter observational study.
Philippe L Pereira, Lukas P Beyer, Katharina Michalik, Christian Stroszczynski, Schicho, Andreas, Andreas Schicho, Pereira, P. L., Beyer, Lukas Philipp, Michalik, K., Stroszczynski, Christian, Philipp Wiggermann, Wiggermann, Phillipp   +11 more
core   +1 more source

Transarterial Chemoembolization [PDF]

JAMA Oncology, 2015
Howard Jack, West, Jill O, Jin
openaire   +2 more sources

Atezolizumab Plus Bevacizumab Treatment for Patients With Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer B2 Stage

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim The optimal treatment strategy for patients with intermediate‐stage hepatocellular carcinoma beyond the up‐to‐seven criteria (Barcelona Clinic Liver Cancer B2) remains uncertain. Although transarterial chemoembolization has long been the standard of care, its efficacy is limited in this subgroup, and systemic therapies have ...
Keishi Ouchi, Masashi Ninomiya, Mio Tsuruoka, Jun Inoue, Atsushi Hiraoka, Kosuke Sato, Kotaro Doi, Kengo Watanabe, Tomoya Sasazaki, Takayoshi Oikawa, Kei Endo, Tamami Abe, Masashi Fujita, Kazumichi Abe, Tomohiro Katsumi, Wataru Sato, Chikara Iino, Nobukazu Tanabe, Hiroshi Numao, Hiromasa Ohira, Hidekatsu Kuroda, Yoshiyuki Ueno, Atsushi Masamune   +22 more
wiley   +1 more source

Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma

, 2011
Purpose: To compare short- and long-term clinical outcomes after conventional transarterial chemoembolization and drug-eluting bead (DEB) transarterial chemoembolization in hepatocellular carcinoma (HCC). Materials and Methods: Patients with unresectable
Bertini M, Parisi G, Romano A, Petruzzi P, Bertoni M, Bargellini I, Bozzi E, Tumino E, Capria A, Bartolozzi C., Federici G, Metrangolo S, Bresci G, Ginanni B, Sacco R, Altomare E, BARTOLOZZI, CARLO   +16 more
core   +1 more source

Safety and efficacy of doxorubicin-eluting superabsorbent polymer microspheres for the treatment of liver metastases from neuroendocrine tumours: preliminary results

Radiology and Oncology, 2017
The aim of the study was to retrospectively evaluate the symptom control, tumour response, and complication rate in patients with liver-predominant metastatic neuroendocrine tumours treated with transarterial chemoembolization using doxorubicin-eluting ...
Bonne Lawrence, Verslype Chris, Laenen Annouschka, Cornelissen Sandra, Deroose Christophe M., Prenen Hans, Vandecaveye Vincent, Van Cutsem Eric, Maleux Geert   +8 more
doaj   +1 more source

Staged caval occlusion enabling en bloc right divisional hepatectomy in two dogs with hepatocellular carcinoma

Veterinary Surgery, EarlyView.
Abstract Objective To describe staged pre‐renal caudal vena cava (CVC) occlusion before en bloc right divisional hepatectomy with segmental caval resection in two dogs with right divisional hepatocellular carcinoma (HCC) involving the CVC. Animals Two client‐owned, 11‐year‐old neutered male dogs (Siberian Husky and Shih Tzu).
Kumiko Ishigaki, Kazushi Asano
wiley   +1 more source

Intraarterial Lidocaine Administration for Pain Control by Water-in-Oil Technique in Transarterial Chemoembolization: in vivo and Randomized Clinical Trial

Journal of Hepatocellular Carcinoma, 2021
Li-Zhou Wang,1,* Xiao-Xia Hu,2,* Xiang-Chun Shen,2,3 Tian-Cheng Wang,4 Shi Zhou1 1Department of Interventional Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, People’s Republic of China; 2The State Laboratory ...
Wang LZ, Hu XX, Shen XC, Wang TC, Zhou S
doaj  

Missed Diagnosis in Alcohol‐Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection

Liver International, Volume 46, Issue 11, November 2026.
ABSTRACT Alcohol‐related hepatocellular carcinoma is an increasingly prevalent consequence of alcohol use and the often‐silent progression of alcohol‐related liver disease. A substantial proportion of patients with alcohol‐related hepatocellular carcinoma are diagnosed at an advanced stage, frequently because underlying liver disease has not been ...
Victoria Mignot, Aurore Baron, Thomas Decaens, Charlotte Costentin   +3 more
wiley   +1 more source